A quality control program for testing fluid ... says will lead to greater efficiency and improve health outcomes. According to the email reportedly sent on Monday by the FDA's Division of Dairy ...

The FDA would embark on a comprehensive look at the nutrients used in infant formula and increase testing for heavy metals ..

The FDA has said it intends to reduce or replace animal testing of some medicines ... now harder to regulate illicit products and could lead to regulatory reviews of new products being delayed.

In an unexpected move, the U.S. Food and Drug Administration announced plans this week to reduce — and possibly replace — animal testing with ... effectiveness, the FDA will begin using ...

Some estimates suggest that, in the first five months of vaccine availability, COVID-19 vaccines saved nearly 140,000 lives in the U.S. If confirmed to lead the FDA, Makary would oversee the ...

Biotech companies developing drugs for hard-to-treat diseases and other ailments are being forced to push back clinical trials and drug testing in ... delays in the FDA’s core functions ...

The U.S. Food and Drug Administration (FDA) on April 10, 2025, announced a significant policy shift aimed at reducing its reliance on animal testing for drug development and incorporating new ...

The U.S. Food and Drug Administration (FDA) announced its plans to end the mandatory animal testing of new drugs, a move that sent AI-enabled biotech companies such as Recursion Pharmaceuticals ...

The FDA plans to reduce and potentially replace animal testing for developing monoclonal antibody therapies and other medications. AI-based computational models are expected to play a larger role ...

US President Donald Trump is receiving rare accolades from animal advocacy groups like PETA for federal agencies' plans to phase out animal testing. The FDA and ... could lead to safer treatments ...

The FDA will phase out animal testing in favor of AI-based computational models of toxicity and cell lines and organoid toxicity testing. "This initiative marks a paradigm shift in drug evaluation ...